Skip to main content
. 2021 Jan 27;3(2):100248. doi: 10.1016/j.jhepr.2021.100248

Fig. 3.

Fig. 3

Rates of response to OCA therapy stratified according to the presence of liver cirrhosis (left panel), PBC-AIH overlap (mid panel) and centre level (right panel).

Response estimated based on POISE (upper panels) and normal range criteria (lower panels) in the overall cohort and treatment completer cohort. ∗p <0.05 and ∗∗p <0.01 using the χ2 test. AIH, autoimmune hepatitis; OCA, obeticholic acid; PBC, primary biliary cholangitis.